EUVIMEDEUVIMED entdecken
Crossref

Outcomes of Acetaminophen Poisoned Patients Treated with and Without Fomepizole: A ToxIC Core Registry Study

Jordan A Woolum iD, Nena Bowman iD, Caitline Phan, Kory Heier, Yana Feygin, Peter Akpunonu iD

Journal of Pharmacy Practice · 10.11.2026

DOI: 10.1177/08971900261507183 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy Practice, online erschienen am 10.11.2026. Verfasst von Jordan A Woolum und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Toxicologist & Emergency Medicine Pharmacist, Pharmacy Services, UK HealthCare, Lexington, KY, USA. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Acute acetaminophen poisoning remains the leading cause of acute hepatic failure in the country. Fomepizole has been suggested to improve outcomes in case reports involving acetaminophen-poisoned patients. The purpose of this study is to evaluate if fomepizole impacts mortality and other clinical outcomes in acetaminophen-poisoned patients seen at the bedside by medical toxicology physicians.

Methods

This was a secondary analysis of cases reported to the Toxicology Investigators Consortium (ToxIC) Core Registry between January 1, 2010, and October 28, 2024. Mono-substance, acetaminophen-poisoned patients managed with NAC therapy were identified. Patients were excluded if they were reported to have a chronic or parenteral acetaminophen exposure or did not receive NAC therapy. Patients were then stratified into two groups: NAC therapy alone (NAC), or NAC therapy in combination with fomepizole (NAC+4MP). The primary outcome of the study was in-hospital mortality. Other secondary clinical endpoints were also collected.

Results

Cases of acute acetaminophen poisoning managed with NAC therapy (n = 3789) were identified and divided into two cohorts: the NAC cohort (n = 3665) and the NAC+4MP cohort (n = 124). Overall, mortality was higher with combination therapy compared with NAC monotherapy (OR 3.59, P = 0.01 [95% CI (1.23, 8.67)]). Metabolic acidosis, AST/ALT > 1000, coagulopathy, vitamin K use, vasopressor use, transfusion, and renal replacement therapy use were also more common in the combination group.

Conclusion

In this large observational database study of acetaminophen poisoning, use of fomepizole and NAC therapy was not associated with improved mortality.

Schlagwörter

Stichwörter der Autor:innen

acetaminophenacetylcysteinefomepizole

Autor:innen und Institutionen

  • Clinical Toxicologist & Emergency Medicine Pharmacist, Pharmacy Services, UK HealthCare, Lexington, KY, USA.
  • Vaccine Preventable Diseases and Immunization Program & Clinical Toxicologist, Tennessee Department of Health, Lipscomb University College of Pharmacy, Nashville, TN, USA.
  • Department of Biostatistics, University of Kentucky, Lexington, KY, USA.
  • Department of Emergency Medicine & Medical Toxicology, UK HealthCare, Lexington, KY, USA.

ORCID-Profile: Jordan A Woolum, Nena Bowman, Peter Akpunonu

Zitieren

APA

Woolum, J. A., Bowman, N., Phan, C., Heier, K., Feygin, Y., & Akpunonu, P. (2026). Outcomes of Acetaminophen Poisoned Patients Treated with and Without Fomepizole: A ToxIC Core Registry Study. Journal of Pharmacy Practice. https://doi.org/10.1177/08971900261507183

Vancouver

Woolum JA, Bowman N, Phan C, Heier K, Feygin Y, Akpunonu P. Outcomes of Acetaminophen Poisoned Patients Treated with and Without Fomepizole: A ToxIC Core Registry Study. Journal of Pharmacy Practice. 2026. doi:10.1177/08971900261507183

BibTeX
@article{Woolum2026,
  author = {Woolum, Jordan A and Bowman, Nena and Phan, Caitline and Heier, Kory and Feygin, Yana and Akpunonu, Peter},
  title = {Outcomes of Acetaminophen Poisoned Patients Treated with and Without Fomepizole: A ToxIC Core Registry Study},
  journal = {Journal of Pharmacy Practice},
  year = {2026},
  doi = {10.1177/08971900261507183}
}
Kostenlos starten →